Wexford Capital LP Tg Therapeutics, Inc. Transaction History
Wexford Capital LP
- $340 Million
- Q1 2025
A detailed history of Wexford Capital LP transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Wexford Capital LP holds 10,000 shares of TGTX stock, worth $365,600. This represents 0.12% of its overall portfolio holdings.
Number of Shares
10,000
Previous 14,000
28.57%
Holding current value
$365,600
Previous $421,000
6.41%
% of portfolio
0.12%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding TGTX
# of Institutions
416Shares Held
88.1MCall Options Held
2.34MPut Options Held
1.94M-
Vanguard Group Inc Valley Forge, PA15.6MShares$571 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$416 Million0.0% of portfolio
-
State Street Corp Boston, MA7.43MShares$272 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.28MShares$120 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.85MShares$104 Million9.29% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.31B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...